Urologist encourages consideration of early apical release HoLEP technique
“For those who do enucleations, I think I would encourage people to highly consider adopting an apical release technique if they haven’t,” says Daniel J. Heidenberg, MD.
“For those who do enucleations, I think I would encourage people to highly consider adopting an apical release technique if they haven’t,” says Daniel J. Heidenberg, MD.
The novel oncolytic immunotherapy cretostimogene grenadenorepvec induced complete responses (CRs) in three-fourths of patients with BCG unresponsive non-muscle-invasive bladder cancer with carcinoma in situ, according…
Increased levels can cause harm, but clinicians can help their patients focus on nourishing their body rather than fearing nutrients by staying current on guidelines…
Sponsored by the AUA Young Urologists Committee, the Speed Mentoring program affords residents and fellows the opportunity to meet with an esteemed group of practicing…
The AUA invites the global urologic community to the 119th AUA Annual Meeting in the dynamic city of San Antonio, TX!
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence…
DD01 is a long-acting dual agonist of glucagon-like peptide-1 and glucagon receptors.
Neal D. Shore, MD, shares what he’s most looking forward to at this year’s American Urological Association Annual Meeting.
Adding the radionuclide therapy ¹⁷⁷Lu-PSMA-617 to enzalutamide improved outcomes in patients with treatment-naïve mCRPC in a phase 2 trial.
Topic: Implementation Science in Urologic Oncology: Translating Evidence into Practice Symposium Goal: To introduce Implementation Science to those new to the field, highlight how implementation…
Alicia Morgans presents a meta-analysis, undertaken with colleagues, analyzing 14 phase three trials on treatment intensification in metastatic hormone-sensitive prostate cancer. The study scrutinizes outcomes…